Russell Green, director product growth for Drug Discovery and Synthetic Biology, Automata, describes three reasons why automation should become an integral part of the vaccine development process.
Abbie Fisher, associate at European Intellectual Property Firm, Withers & Rogers, discusses patenting a new frontier in personalised medicine with AI-powered biomarker discovery.
Adnan Khan, manager of pharma industries at Beckhoff UK, discusses the challenges of pharmaceutical production lines and how next-generation motion can help.
Mark Hilhorst, CEO of Jekson Vision, provides insight into the stringent quality checks needed that are crucial to improve patient safety in the pharma market, and how automation solutions can help with this, while meeting growing market demand.
Rebekah Jordan talks with Peter Shone, chief technology officer, iethico, about its latest AI-powered platform that can give clear indications of medicine shortages and predict future supply chain challenges - and what this means for pharmacists.
Allison Hoffman, global product manager, Cell Therapy Technologies, Terumo BCT, discusses how automation is leading the way to optimising autologous manufacturing in the C> sector.
Mark Yeeles, VP Industrial Automation, Schneider Electric, examines five important areas pharmaceutical facilities need to be aware of to transform their operations and improve production.
Rebekah Jordan sits with Marty Gauvin, CEO of Fertilis, to discuss its IVF treatment innovation that replicates nature and automates the cell culture process, as well as its potential applications in regenerative medicine.
Jason Smith, CTO, AI & Analytics, Within3, describes the possibilities made by AI in supporting the life sciences sector, and how it can allow pharma experts to produce real time results and yield better insights.
Ari Goldfarb, CEO, Kando, discusses how innovative technologies and artificial intelligence tools are advancing wastewater analysis and could potentially mitigate the effects, or even prevent, future pandemics.
Jon Brewin, business development manager for AutoStore, discusses increasing demands on pharmaceutical supply chains and how automation can improve lead times.
Withers & Rogers gives an insight into the new ways that AI is helping to accelerate drug discovery and highlights the challenges that exist when bringing such innovations to market.
